Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor

Virology

Volumn 273, Issue 1, 2000, Pages 80-89

  Matsuyama, Shutoku ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; VIRUS RECEPTOR; VITRONECTIN;

ANIMAL CELL; ARTICLE; HEPATITIS; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SYNCYTIUM; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 0034691585     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0409     Document Type: Article

References (51)

1. Arita M., Horie H., Arita M., Nomoto A. Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J. Virol. 73:1999;1066-1074.
2. Beauchemin N. Nomenclature announcement. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:1999;243-249.
3. Boyle J. F., Weismiller D. G., Holmes K. V. Genetic difference to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:1987;185-189.
4. Castro R. F., Perlman S. CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:1995;8127-8131.
5. Chen D. S., Asanaka M., Yokomori K., Wang F., Hwang S. B., Li H., Lai M. M. C. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. J. Virol. 92:1995;12095-12099.
6. Chen W., Baric R. S. Molecular anatomy of mouse hepatitis virus persistence: Coevolution of increased host cell resistance and virus virulence. J. Virol. 70:1996;3947-3960.
7. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell fusion. Virology. 119:1982;358-371.
8. Dalziel R. G., Lampert P. W., Talbot P. J., Buchmeier M. J. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:1986;463-471.
9. De Groot R. J., Luytjes W., Horzinek M. C., Van der Zeijst B. A. M., Spaan W. J. M., Lenstra J. A. Evidence for a coiled-coil structure in the spike of coronaviruses. J. Mol. Biol. 196:1987;963-966.
10. Dveksler G. S., Diffenbach C. W., Cardellichio C. B., Mccuaig K., Pensiero M. N., Jiang G. S., Beauchemin N., Holmes K. V. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1993;1-8.
11. Dveksler G. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G., Holmes K. V., Diffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
12. Fleming J. O., Trousdale M. D., El-Zaatari F. A. K., Stohlman S. A., Weiner L. P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:1986;869-875.
13. Flory E., Pfleiderer M., Stuhler A., Wege H. Induction of protective immunity against coronavirus-induced encephalomyelitis: Evidence for an important role of CD8+ T cells in vivo. Eur. J. Immunol. 23:1993;1757-1761.
14. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
15. Gallagher T. M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:1996;4683-4690.
16. Gallagher T. M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:1997;3129-3137.
17. Gallagher T. M., Escarmis C., Buchmeier M. J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 65:1991;1916-1938.
18. Hirano N., Fujiwara K., Hino S., Matsumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:1974;298-302.
19. Kubo H., Takase S. Y., Taguchi F. Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV cl-2 variant. J. Gen. Virol. 74:1993;1421-1425.
20. Kubo H., Yamada Y. K., Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:1994;5403-5410.
21. Lai M. M. C., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
22. Luo Z., Weiss S. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology. 244:1998;483-494.
23. Matsubara Y., Watanabe R., Taguchi F. Neurovirulence of six different murine coronavirus JHMV variants for rats. Virus Res. 20:1991;45-58.
24. Nedellec P., Dveksler G. S., Daniels E., Turbide C., Chow B., Basile A. A., Holmes K. V., Beauchemin N. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:1994;4525-4537.
25. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
26. Ohtsuka N., Taguchi F. Mouse susceptibility to mouse hepatitis virus infection links with viral receptor genotype. J. Virol. 71:1997;8860-8863.
27. Ohtsuka N., Yamada Y. K., Taguchi F. Difference of virus-binding activity of two receptor proteins for mouse hepatitis virus. J. Gen. Virol. 77:1996;1683-1692.
28. Phillips J. J., Chua M. M., Lavi E., Weiss S. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:1999;7752-7760.
29. Rao P. V., Kumari S., Gallagher T. M. Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology. 229:1997;336-348.
30. Routledge E., Stauber R., Pfleiderer M., Siddell S. G. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J. Virol. 65:1991;254-262.
31. Saeki K., Ohtsuka N., Taguchi F. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 71:1997;9024-9031.
32. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
33. Skinner M. A., Siddell S. G. Coronavirus JHM: Nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acid Res. 11:1983;5045-5054.
34. Spaan W., Cavanagh D., Horzinek M. C. Coronaviruses: Structure and genome expression. J. Gen. Virol. 69:1988;2939-2952.
35. Stauber R., Pfleiderer M., Siddell S. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J. Gen. Virol. 74:1993;183-191.
36. Sturman L. S., Ricard C. S., Holmes K. V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:1985;904-911.
37. Suzuki H., Taguchi F. Analysis of the receptor binding site of murine coronavirus spike glycoprotein. J. Virol. 70:1996;2632-2636.
38. Taguchi F. Fusion formation by uncleaved spike protein of murine coronavirus JHMV variant cl-2. J. Virol. 67:1993;1195-1202.
39. Taguchi F. The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J. Virol. 69:1995;7260-7263.
40. Taguchi F., Ikeda T., Shida H. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73:1992;1065-1072.
41. Taguchi F., Kubo H., Takahashi H., Suzuki H. Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV. Virology. 208:1995;67-74.
42. Taguchi F., Siddell S. G., Wege H., ter Meulen V. Characterization of a variant virus selected in rat brain after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:1985;429-435.
43. Taguchi F., Yamada A., Fujiwara K. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: Enhanced antiviral activity of macrophages. Infect. Immun. 29:1980;42-49.
44. Wang F.-I., Fleming J. O., Lai M. M. C. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic site affecting neuropathogenicity. Virology. 186:1992;742-749.
45. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
46. Williams R. K., Jiang G. S., Holmes K. V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA. 88:1991;5533-5536.
47. Williams R. K., Jiang G. S., Snyder S. W., Frana M. F., Holmes K. V. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a non-functional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:1990;3817-3823.
48. Yamada Y. K., Takimoto K., Yabe M., Taguchi F. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology. 227:1997;215-219.
49. Yamada K. Y., Yabe M., Yamada A., Taguchi F. Detection of mouse hepatitis virus by the polymerase chain reaction and its application to the rapid diagnosis of infection. Lab. Anim. Sci. 43:1993;285-290.
50. Yokomori K., Lai M. M. C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:1992a;6164-6169.
51. Yokomori K., Lai M. M. C. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: Implication for the requirement of a second factor for virus infection. J. Virol. 66:1992b;6931-6938.